Brief: Bone Biologics Advances Preparations For Nb1 Pilot Clinical Trial With Engagement Of Contract Research Organization
26/01/2023 13:46
Jan 26 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS ADVANCES PREPARATIONS FOR NB1 PILOT
CLINICAL
TRIAL WITH ENGAGEMENT OF CONTRACT RESEARCH ORGANIZATION
* BONE BIOLOGICS CORP- TRIAL IS EXPECTED TO BE INITIATED IN
SECOND
HALF OF 2023, PENDING APPROVAL FROM MONASH HEALTH SYSTEM ETHICS
COMMITTEE IN AUSTRALIA
Source text for Eikon: ID:nBw7G52mda
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview